Non-Small Cell Lung Carcinoma Market Overview and Forecast
FAQ's
Answer : According to Precedence Research, the global cancer immunotherapy market size was reached at USD 85 billion in 2021 and is expected to hit around USD 277.1 billion by 2030.
Answer : The global cancer immunotherapy market to grow at a CAGR of 12.6% from 2021 to 2030.
Answer : The rising prevalence of various cancer such as colorectal cancer, bowel cancer, breast cancer, and lungs cancer among the global population and rising adoption of the immunotherapy to treat cancer is boosting the growth of the global cancer immunotherapy market.
Answer : The major players operating in the cancer immunotherapy market are Amgen, Inc., Astrazeneca, PLC, Bayer AG, Bristol-Myers Squibb Company, Eli Lily And Company, F. Hoffmann-La Roche, Ltd, Pfizer, Inc., Johnson & Johnson, Merck KGAA, Novartis AG.
Answer : North America dominated the global cancer immunotherapy market in 2020 and is estimated to sustain its dominance during the forecast period.
Get a Sample of this Report
Non-Small Cell Lung Carcinoma Market
